-
公开(公告)号:US07700628B2
公开(公告)日:2010-04-20
申请号:US11719415
申请日:2005-11-10
申请人: Ankush Baburao Argade , Theodore Goodson, Jr. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Louise Tebbe , Michael Robert Wiley , Ying Kwong Yee
发明人: Ankush Baburao Argade , Theodore Goodson, Jr. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Louise Tebbe , Michael Robert Wiley , Ying Kwong Yee
IPC分类号: C07D413/10 , C07D413/14 , C07D401/10 , C07D401/02 , C07D401/14 , C07D401/12 , C07D409/10 , C07D243/08 , C07D213/75 , A61K31/381 , A61K31/4402 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/5377 , A61K31/551
CPC分类号: C07D211/46 , C07C229/38 , C07D213/75 , C07D295/192 , C07D333/38 , C07D401/12 , C07D401/14 , C07D409/06 , C07D409/14 , C07D413/12 , C07D417/12
摘要: This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. An example of a compound of formula (I) is (a).
摘要翻译: 本申请涉及如本文所定义的式(I)化合物(或其化合物或前药的药学上可接受的盐),其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途,以及 其制备方法及其中间体。 式(I)化合物的实例是(a)。
-
公开(公告)号:US20090227566A1
公开(公告)日:2009-09-10
申请号:US11719415
申请日:2005-11-10
申请人: Ankush Baburao Argade , Theodore Goodson, JR. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Lousie Tebbe , Michael Robert Wiley , Ying Kwong Yee
发明人: Ankush Baburao Argade , Theodore Goodson, JR. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Lousie Tebbe , Michael Robert Wiley , Ying Kwong Yee
IPC分类号: A61K31/551 , A61K31/5377 , A61K31/445 , C07D243/08 , C07D413/12 , C07D401/12 , C07D211/98
CPC分类号: C07D211/46 , C07C229/38 , C07D213/75 , C07D295/192 , C07D333/38 , C07D401/12 , C07D401/14 , C07D409/06 , C07D409/14 , C07D413/12 , C07D417/12
摘要: This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. An example of a compound of formula (I) is (a).
摘要翻译: 本申请涉及如本文所定义的式(I)化合物(或其化合物或前药的药学上可接受的盐),其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途,以及 其制备方法及其中间体。 式(I)化合物的实例是(a)。
-